Park Medi World Limited has successfully completed the acquisition of Krishna Super-speciality Hospital in Bathinda for ₹40.00 crores, marking a significant expansion in its healthcare infrastructure. The Board of Directors approved the acquisition during a meeting held on January 05, 2026, from 8:00 a.m. to 9:25 a.m., involving the purchase of 100% shareholding of the hospital facility. The company filed the acquisition details with BSE Limited and National Stock Exchange of India Limited under Regulation 30 of SEBI LODR requirements.

Acquisition Details

The acquisition involves Krishna Super-speciality Hospital, which is owned and operated by Mahip Hospitals Private Limited. The transaction represents an all-cash consideration deal worth ₹40.00 crores for complete ownership of the healthcare facility.

Hospital Infrastructure and Capabilities

Krishna Super-speciality Hospital is strategically positioned in the heart of Bathinda and serves as a vital healthcare hub for both urban and rural districts. The facility has been designed as a 250-bedded hospital with comprehensive medical infrastructure including modular operation theatres and automated laboratories.

Key Facility Features:

• Total Capacity: 250 beds including 70 ICU beds
• Advanced Infrastructure: Modular operation theatres and automated laboratories
• Strategic Location: Centralized position serving multiple districts
• Specialties: Multiple super-specialty services

Medical Services and Specializations

The hospital provides comprehensive medical care across various super-specialties, positioning it as a major healthcare provider in the region. The facility offers advanced medical services supported by modern infrastructure and highly-trained experienced medical professionals.

Core Medical Specialties:

• Cardiac Sciences and Endocrinology
• Neurosciences and Oncology & Radiation
• Orthopaedics & Joint Replacement
• Urology & Nephrology
• Critical Care and Gastroenterology
• Advanced diagnostics and emergency services
• Women & child health services

Financial Performance and Background

Mahip Hospitals Private Limited, incorporated on October 30, 2015, has shown significant growth in recent years. The company has its registered office at H. No. 245, Sector 16-A, Chandigarh with an authorized capital of ₹15.00 lakhs and paid-up capital of ₹13.50 lakhs.

Strategic Impact and Management Transition

Park Medi World Limited has been managing Krishna Super-speciality Hospital's operations since July 2025 and has now transitioned from managing to fully acquiring the facility from the current promoters. This acquisition is not a related party transaction, and no promoter or group companies have any interest in the acquired entity.

Dr. Ankit Gupta, Managing Director of Park Medi World Limited, emphasized the acquisition's significance in bridging the healthcare gap for rural and economically-weaker communities, providing metropolitan-grade care locally and affordably. The addition of Krishna Super-speciality Hospital increases Park Group's hospital capacity and strengthens its healthcare infrastructure, supporting the company's strategic plan to reach a total of 5,260 beds by March 2028 across its 14 operational hospitals and seven hospitals under various stages of execution.

Park Medi World Limited has successfully acquired Febris Multi-speciality Hospital in Narela, New Delhi, through its wholly-owned subsidiary Blue Heavens Healthcare Private Limited. The acquisition, valued at ₹50.68 crores, was completed through the corporate insolvency resolution process.

Acquisition Details

The transaction involved acquiring 100% shareholding in Durha Vitrak Private Limited, which owns and operates Febris Multi-speciality Hospital. The acquisition was structured as a cash transaction through the corporate insolvency resolution process under the Insolvency and Bankruptcy Code, 2016.

Hospital Infrastructure and Capacity

Febris Multi-speciality Hospital is designed as a 200-bed multi-speciality healthcare facility constructed over 1,10,000 square feet of covered area. The hospital is strategically located in Narela, New Delhi, providing easy accessibility from districts in Haryana and Uttar Pradesh, particularly rural areas.

The target entity, Durha Vitrak Private Limited, was incorporated on August 1, 1986, with its registered office at Plot No. 20, Sector A-7 Narela, Delhi. The company has an authorized capital of ₹10 crores and paid-up capital of ₹10 lakhs. However, the entity was under corporate insolvency resolution process and remained non-operational since 2019, resulting in no revenue generation in the last three years.

Strategic Impact and Objectives

The acquisition aligns with Park Group's cluster-based growth model and expansion strategy. Located in the densely populated area of Narela, the facility is positioned to bridge the healthcare gap for low-income families by providing dependable, high-quality medical services at affordable rates.

Dr. Ankit Gupta, Managing Director of Park Medi World Limited, stated that the acquisition reinforces the company's commitment to making affordable, world-class healthcare accessible across the Northern Region. The hospital will strengthen the regional network while upholding the group's mission of wellness for all.

Company Background

Park Group operates as North India's second-largest hospital chain, currently managing 14 hospitals with a combined capacity of 3,250 beds. The group has established presence across key cities including Delhi, Gurgaon, Faridabad, Panipat, Karnal, Sonipat, Ambala, Mohali, Patiala, Bathinda, Behror, and Jaipur.

The healthcare services span multiple super-specialities including cardiology, neurology, oncology, orthopaedics, gastroenterology, critical care, nephrology, and women and child health. Each facility is equipped with modern medical infrastructure, advanced diagnostics, 24x7 emergency support, and multi-disciplinary teams delivering evidence-based care.

Regulatory Compliance

The acquisition disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transaction does not fall within related party transactions, and promoter/promoter group/group companies have no interest in the entity being acquired.